DRKS00034580招募中不适用
Real-life longitudinal observational data collection to evaluate the efficacy and safety of the type I interferon receptor antagonist anifrolumab in patients with systemic lupus erythematosus - SLANI
Medizinische Klinik 3- Rheumatologie und Immunologie. Universitätsklinikum Erlangen0 个研究点目标入组 50 人开始时间: 2024年7月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Subject must be able to understand and communicate with the investigator and
- •comply with the requirements of the study, must give a written and signed and
- •dated informed consent before any study assessment is performed
- •2. Written informed consent
- •3. Age = 18
- •4. Diagnosis of SLE according to ACR/EULAR 2019 classification criteria.
- •5. Ongoing treatment with Anifrolumab as part of the clinical routine
排除标准
- •1. Incapability of giving informed consent to study participation
- •2. Off-label treatment with Anifrolumab
研究者
相似试验
招募中
Unknown
Prospective observational study on data collection in lower gastrointestinal endoscopy and development of image diagnosis support software using artificial intelligence (AI)Patients scheduled for lower gastrointestinal endoscopy or treatmentJPRN-jRCT1030230661Tada Tomohiro6,600
已完成
不适用
A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in males <= 17 years of age undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy.bronze Schilder disease10029299AdrenoleukodystrophyNL-OMON47132bluebird bio6
招募中
4 期
Study the effectiveness of Hydroxyzine hydrochloride in Patients with Persistent ItchingCTRI/2017/06/008847Dr Reddys Laboratories Ltd400
招募中
不适用
A longitudinal prospective, observational, cohort study in lactating mothers and their newborns to further unravel the complexity of human milkNL-OMON53220utricia Research120
尚未招募
不适用
Comparison of suspected or negative cases with confirmed cases of COVID-19 at Max HospitalCTRI/2020/04/024772Max Healthcare A Unit of Devki Devi Foundation